A similar staining pattern was observed with another human tau antibody, CP27, and this clear difference in tau staining pattern was also observed among brain regions of control and AD individuals (Figs. 2, 3, Additional file 1: S2 and S3). Here, MAPT is linked to Alzheimer disease.